Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Rilpivirine 900mg/3ml prolonged-release suspension for injection vials |
BNF code | 0503010AGAAABAB |
Virtual Therapeutic Moiety | Rilpivirine |
Abbreviated name | Rilpivirine 900mg/3ml prolonged-release inj vials |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 3.000 |
Unit dose form units | ml |
Unit dose unit of measure | vial |
Virtual Product Ingredient | |
---|---|
Ingredient | Rilpivirine |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 300.000 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | ml |
Ontology Drug Form & Route | |
Form & Route | suspensioninjectionprolonged-release.intramuscular |
Dose Form | |
Formulation | Prolonged-release suspension for injection |
Drug Route | |
Route | Intramuscular |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Rekambys 900mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) | |
Virtual Medicinal Product Packs | |
Rilpivirine 900mg/3ml prolonged-release suspension for injection vials 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.